In one study, COVID-19 patients with an admission CRP ≥65.1 mg/l were more likely to require high-flow oxygen, noninvasive or invasive mechanical ventilation, continuous renal replacement therapy or extracorporeal membrane oxygenation (OR: 8.9; 95% CI 1.0–74.2) [26]. The gene discussed is CRP; the disease is COVID-19.